TandemLife

TandemLife

Develops, manufactures, and markets innovative medical device products to provide Cardiologists and Cardiac Surgeons. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-
*

$250m

Valuation: $250m

Acquisition
Total Funding-

Recent News about TandemLife

Edit
More about TandemLifeinfo icon
Edit

CardiacAssist, now part of LivaNova, specializes in developing advanced temporary life support solutions for patients experiencing cardiac and respiratory failure. The company operates in the medical device market, focusing on short-term percutaneous cardiac support devices. CardiacAssist's core products include the LifeSPARC System, TandemLife Kit, TandemHeart Kit, TandemLung Kit, and ProtekDuo Kit, which are designed to be easy to use and provide critical support in emergency situations.

The company primarily serves hospitals and healthcare providers who require reliable and efficient life support systems for their patients. By leveraging over two decades of experience in advanced circulatory support, CardiacAssist has positioned itself as a leader in the field, continuously innovating to meet the evolving needs of the healthcare industry.

CardiacAssist's business model revolves around the sale of its proprietary life support systems and related consumables. The company generates revenue through direct sales to healthcare institutions and through partnerships with medical distributors. Additionally, CardiacAssist offers 24/7 clinical support to ensure optimal use of their products, further enhancing their value proposition.

Keywords: temporary life support, cardiac care, respiratory care, medical devices, percutaneous support, healthcare innovation, LifeSPARC, TandemLife, ProtekDuo, LivaNova.